India  

Covid-19: China clears 2 more vaccines for human trials

Video Credit: HT Digital Content - Duration: 02:20s - Published
Covid-19: China clears 2 more vaccines for human trials

Covid-19: China clears 2 more vaccines for human trials

China has cleared two more experimental Covid-19 vaccines for human trials.

The vaccines are being developed by Sinovac Biotech, and Wuhan Institute of Biological Products.

Chinese authorities had earlier cleared a vaccine for clinical trials in March 2020.

Wu Yuanbin, Director of Science and Technology for Social Development in the Ministry of Science and Technology said that the vaccines cleared for clinical trials recently are 'based on conventional techniques', their production is 'mature in technique' and the standards are more 'controllable'.

China's Wuhan is the original epicentre of the outbreak of the Sars-Cov-2 virus, colloquially known as Coronavirus.


You Might Like


Related videos from verified sources

Covid-19: India begins testing possible cure on patients at PGI Chandigarh [Video]

Covid-19: India begins testing possible cure on patients at PGI Chandigarh

India's premier scientific research body announced Covid drug trial. CSIR-Indian Institute of Integrative Medicine's director spoke on the trials. Sepsivac, a new drug used against sepsis, being tried..

Credit: HT Digital Content     Duration: 02:29Published
Monkeys Given Oxford Vaccine After COVID-19 Exposure Didn’t Catch Virus, Human Trials Begin [Video]

Monkeys Given Oxford Vaccine After COVID-19 Exposure Didn’t Catch Virus, Human Trials Begin

Six monkeys were heavily exposed to the coronavirus but didn’t catch it after receiving a vaccine, according to a new study from Oxford University.

Credit: Veuer     Duration: 00:38Published
Britain starts human trials on COVID-19 vaccine [Video]

Britain starts human trials on COVID-19 vaccine

OXFORD, ENGLAND — The University of Oxford has initiated human trials for the first COVID-19 vaccine in Europe, according to the BBC. Citing the university, BBC reports on April 23 that the..

Credit: TomoNews US     Duration: 01:41Published